Related Experiment Video
Updated: Jan 23, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Watchman Occlusion in Long-Standing Persistent Atrial Fibrillation: Larger Left Atrial Appendages With Greater
Matthew S Glassy1, William Wung1, Sarah Westcott1
1Division of Cardiovascular Medicine, University of California, Davis, Davis, California.
Insights
Patients with long-standing persistent atrial fibrillation (LSPAF) have larger left atrial appendage (LAA) sizes, requiring larger Watchman devices and experiencing more residual leaks post-procedure. LSPAF patients may need closer follow-up.
Area of Science:
- Cardiology
- Medical Devices
- Echocardiography
Background:
- Atrial fibrillation (AF) burden correlates with left atrial (LA) remodeling and enlargement.
- Long-standing persistent atrial fibrillation (LSPAF) may influence anatomical characteristics relevant to LAA occlusion.
- Understanding anatomical differences is crucial for optimizing Watchman device implantation.
Purpose of the Study:
- To compare anatomical measurements and procedural outcomes in patients with and without LSPAF undergoing Watchman LAA occlusion.
- To evaluate the impact of LSPAF on LAA dimensions, device selection, and post-procedure residual leak.
- To identify potential risk stratification factors for Watchman procedures based on AF history.
Main Methods:
- Retrospective analysis of 101 consecutive Watchman LAA occlusion cases.
- Patients categorized into LSPAF (n=48) and non-LSPAF (n=53) groups.
- Transesophageal echocardiography (TEE) used to measure LAA ostial diameter, depth, device compression, and residual leak.
Main Results:
- LSPAF patients exhibited significantly larger LAA ostial diameters and depths across multiple TEE views compared to non-LSPAF patients (p<0.0001).
- A higher proportion of LSPAF patients received larger Watchman devices (77% vs. 46%, p=0.003).
- While initial leak rates were similar, LSPAF patients had a higher incidence of moderate residual leaks at 6-week follow-up TEE (27% vs. 4%, p=0.04).
Conclusions:
- Patients with LSPAF demonstrate significantly larger LAA dimensions, necessitating larger implant devices.
- LSPAF is associated with an increased risk of moderate residual LAA leaks post-Watchman implantation.
- LSPAF may indicate a higher-risk patient group requiring more intensive follow-up after LAA occlusion.
Objectives:
This study sought to compare patients with and without long-standing persistent atrial fibrillation (LSPAF) undergoing Watchman left atrial appendage (LAA) occlusion.
Background:
An increased burden of atrial fibrillation is associated with progressive left atrial remodeling and enlargement.
Methods:
Transesophageal echocardiography (TEE) measures of LAA ostial diameter and depth, device compression, and residual leak were evaluated in 101 consecutive Watchman cases. The patients were categorized into LSPAF (n = 48) or non-LSPAF (n = 53) groups and compared.
Results:
The average LAA ostial diameter for LSPAF versus non-LSPAF by TEE omniplane at 0° was 21.1 ± 4.1 mm versus 18.2 ± 3.6 mm (p = 0.0002); at 45° was 18.7 ± 3.4 mm versus 16.3 ± 3.1 mm (p = 0.0004); at 90° was 19.6 ± 3.8 mm versus 16.2 ± 3.4 mm (p = 0.00001); and at 135° was 21.0 ± 4.1 mm versus 18.0 ± 4.1 mm (p = 0.0005). The average LAA depth for LSPAF versus non-LSPAF by TEE at 0° was 28.1 ± 6.4 mm versus 25.2 ± 4.9 mm (p = 0.02); at 45° was 27.9 ± 5.8 mm versus 25.1 ± 4.3 mm (p = 0.007); at 90° was 27.2 ± 5.2 mm versus 22.8 ± 3.7 mm (p = 0.0001); and at 135° was 25.6 ± 5.4 mm versus 21.5 ± 3.8 mm (p = 0.0001). In successfully treated patients, 77% of the LSPAF group received larger device (27, 30, or 33 mm) implants versus only 46% in the non-LSPAF group (p = 0.003). While both groups had similar rates of moderate (3 to 5 mm) leaks at implant (2% vs. 0%; p = 0.14), 27% of the LSPAF vs. 4% of the non-LSPAF group had moderate leaks (p = 0.04) on 6-week follow-up TEE.
Conclusions:
Patients with LSPAF have significantly larger LAA sizes, require larger devices, and have more residual leak on follow-up TEE. LSPAF may represent a higher risk group that warrants more stringent long-term follow-up.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Residual Stresses
Residual Plots
When the residual values are plotted against the variable x, it is called a residual...
Surface Appendages of Archaea

